Rising Prevalence Of Neurological Disorders Fuels Demand For Neurogenetic Testing: Powering Innovation and Expansion in the Global Neurogenetic Testing Market by 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Neurogenetic Testing Market Through 2025?
The sphere of neurogenetic testing has seen swift expansion lately, projected to increase its valuation from $0.61 billion in 2024 to $0.7 billion spanning into 2025, reflecting an annual compounded growth rate of 13.5%. This upward trajectory throughout the past period stems from several underlying factors, including a heightened incidence of neurological disorders, greater investment in life science investigations, the rising occurrence of Parkinson's disease, an escalation in cancer diagnoses, and growing recognition among medical practitioners regarding the utility of these tests.

What's the Projected Size of the Global Neurogenetic Testing Market by 2029?
Anticipated rapid expansion characterizes the trajectory for the neurogenetic testing market, projected to reach a valuation of $1.12 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.7% throughout this forecast duration, a surge fundamentally driven by the broadening utilization across personalized medical approaches, the escalating prevalence of long-term health issues, an augmentation in healthcare facilities like hospitals, a multiplication of diagnostic labs, and a heightened necessity for detecting ailments sooner, concurrent with key developments involving technological progress, wider acceptance of testing procedures that avoid surgery, the creation of innovative offerings, the formation of key partnerships, and the discovery of new indicators for nervous system disorders.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

Top Growth Drivers in the Neurogenetic Testing Industry: What's Accelerating the Market?
The increasing incidence of conditions affecting the nervous system-which encompasses the brain, spinal cord, and nerves-is anticipated to be a major catalyst for expansion within the neurogenetic testing sector. These neurological ailments arise from various factors such as genetic susceptibility, infectious agents, physical injury, exposure to harmful substances, immune system reactions, and degenerative processes. By furnishing specific details regarding hereditary risk elements, guiding therapeutic selections, and enabling patients and their relatives to make knowledgeable decisions regarding their healthcare, neurogenetic testing considerably boosts the identification, therapy, and handling of these disorders, ultimately leading to better patient management and results. Illustratively, data released in April 2022 by the European Brain Council, an organization headquartered in Belgium, showed that millions worldwide are affected by upwards of 600 neurological diseases alongside almost 300 psychiatric issues, notably including 65 million individuals suffering from epilepsy. Within Europe alone, ten and a half million individuals currently live with dementia, with forecasts suggesting this number will climb to 18.7 million by the year 2050, thus solidifying the expectation that the escalating rate of neurological disorders will fuel the growth trajectory of the neurogenetic testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16131&type=smp

What Trends Will Shape the Neurogenetic Testing Market Through 2029 and Beyond?
Leading enterprises within the neurogenetic testing sector are focusing on creating novel offerings, like whole-genome sequencing technology, specifically to boost the precision and breadth of genetic evaluations, thus facilitating broader and more tailored testing protocols for afflictions of the nervous system.The complete DNA sequence of an organism's entire genetic makeup is ascertained through whole-genome sequencing (WGS), which stands as an exhaustive genetic evaluation technique.As an illustration, in the third month of 2024, Nucleus Genomics, an American firm specializing in genetic interpretation, introduced a new DNA assessment solution.This particular system grants individuals enhanced insight into their inherent genetic susceptibilities, thereby supporting better-informed choices concerning their personal health status and overall wellness.Leveraging state-of-the-art technology alongside specialized genetic guidance, Nucleus Genomics is poised to transform the sphere of genetic screening by making the capabilities of whole-genome sequencing directly accessible to the public, thereby initiating a revolution in genomic healthcare.

What Are the Main Segments in the Neurogenetic Testing Market?
The neurogenetic testingmarket covered in this report is segmented -

1) By Type: Microarray Analysis; Whole-Exome Sequencing (WES); Multiplex Ligation Dependent Probe Amplification (MLPA); Polymerase Chain Reaction (PCR) Tests; Other Types
2) By Disease: Rare Genetic Disorder; Cancer; Cystic Fibrosis; Sickle Cell Anemia; Duchenne Muscular Dystrophy; Thalassemia; Huntington's Disease; Fragile X Syndrome; Other Diseases
3) By End-Users: Hospitals; Specialty Clinics; Research Institutes; Diagnostics Laboratories

Subsegments:
1) By Microarray Analysis: Comparative Genomic Hybridization (CGH) Microarray; Single Nucleotide Polymorphism (SNP) Microarray; Gene Expression Microarray
2) By Whole-Exome Sequencing (WES): Targeted Exome Sequencing; Clinical Exome Sequencing; Research-Grade Exome Sequencing
3) By Multiplex Ligation Dependent Probe Amplification (MLPA): MLPA For Copy Number Variation; MLPA For Methylation Analysis; MLPA For Specific Disease Detection
4) By Polymerase Chain Reaction (PCR) Tests: Quantitative PCR (qPCR); Reverse Transcription PCR (RT-PCR); Digital PCR (dPCR)
5) By Other Types: Next-Generation Sequencing (NGS); Southern Blotting; Fluorescence In Situ Hybridization (FISH); Sanger Sequencing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16131&type=smp

Which Top Companies are Driving Growth in the Neurogenetic Testing Market?
Major companies operating in the neurogenetic testing market are Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children's, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc., MedGenome Labs, CENTOGENE, Baylor Genetics, Victorian Clinical Genetics Services

Which Regions Will Dominate the Neurogenetic Testing Market Through 2029?
North America was the largest region in the neurogenetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16131

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.